Mackenzie L. Cottrell

1.8k total citations
78 papers, 1.2k citations indexed

About

Mackenzie L. Cottrell is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mackenzie L. Cottrell has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 46 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Mackenzie L. Cottrell's work include HIV/AIDS Research and Interventions (56 papers), HIV Research and Treatment (46 papers) and HIV/AIDS drug development and treatment (33 papers). Mackenzie L. Cottrell is often cited by papers focused on HIV/AIDS Research and Interventions (56 papers), HIV Research and Treatment (46 papers) and HIV/AIDS drug development and treatment (33 papers). Mackenzie L. Cottrell collaborates with scholars based in United States, Spain and Australia. Mackenzie L. Cottrell's co-authors include Angela D. M. Kashuba, Craig Sykes, Heather M. A. Prince, Nicole White, Evan S. Dellon, Kristine B. Patterson, Ryan D. Madanick, Michael G. Hudgens, Julie A. Nelson and Nicholas J. Shaheen and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Mackenzie L. Cottrell

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mackenzie L. Cottrell United States	16	879	486	367	118	110	78	1.2k
Craig Sykes United States	20	864 1.0×	639 1.3×	339 0.9×	114 1.0×	99 0.9×	67	1.4k
Jia‐Hua Zheng United States	19	914 1.0×	489 1.0×	386 1.1×	107 0.9×	91 0.8×	40	1.2k
Mauro Zaccarelli Italy	25	1.2k 1.4×	953 2.0×	498 1.4×	218 1.8×	77 0.7×	91	1.7k
Manisha Ghate India	16	575 0.7×	345 0.7×	482 1.3×	91 0.8×	123 1.1×	81	1.1k
Jonathan Ainsworth United Kingdom	18	792 0.9×	515 1.1×	492 1.3×	236 2.0×	73 0.7×	44	1.2k
Susan L. Ford United States	22	1.5k 1.7×	1.1k 2.3×	391 1.1×	215 1.8×	52 0.5×	56	1.8k
Didier Laureillard France	20	858 1.0×	354 0.7×	759 2.1×	56 0.5×	51 0.5×	84	1.3k
Kittipong Rungruengthanakit Thailand	16	387 0.4×	220 0.5×	311 0.8×	35 0.3×	122 1.1×	26	714
Ed Wilkins United Kingdom	22	671 0.8×	153 0.3×	616 1.7×	92 0.8×	82 0.7×	57	1.4k
Katharine Darling Switzerland	21	758 0.9×	188 0.4×	583 1.6×	119 1.0×	77 0.7×	76	1.5k

Countries citing papers authored by Mackenzie L. Cottrell

Since Specialization

Citations

This map shows the geographic impact of Mackenzie L. Cottrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mackenzie L. Cottrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mackenzie L. Cottrell more than expected).

Fields of papers citing papers by Mackenzie L. Cottrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mackenzie L. Cottrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mackenzie L. Cottrell. The network helps show where Mackenzie L. Cottrell may publish in the future.

Co-authorship network of co-authors of Mackenzie L. Cottrell

This figure shows the co-authorship network connecting the top 25 collaborators of Mackenzie L. Cottrell. A scholar is included among the top collaborators of Mackenzie L. Cottrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mackenzie L. Cottrell. Mackenzie L. Cottrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mollan, Katie R., Brian W. Pence, Daniel Westreich, et al.. (2025). Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women with HIV on efavirenz. AIDS. 39(9). 1197–1203.

Niubó, Jordí, Amanda P. Schauer, Sandra Morenilla, et al.. (2025). Cabotegravir and Rilpivirine Concentrations and HIV-1 RNA Suppression in Genital Fluids and Rectum in People with HIV on Long-Acting Intramuscular Cabotegravir Plus Rilpivirine Antiretroviral Therapy. The Journal of Infectious Diseases. 233(2). 261–266.

Anderson, Peter L., et al.. (2025). Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 100(2). 162–169.

Le, Thuy, Mackenzie L. Cottrell, Craig Sykes, et al.. (2025). Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV prevention. Journal of Controlled Release. 386. 114166–114166.

Hightow‐Weidman, Lisa, David Benkeser, Mackenzie L. Cottrell, et al.. (2024). Prepared, Protected, EmPowered (P3): Primary Results of a Randomized Controlled Trial Using a Social Networking, Gamification, and Coaching App to Promote Pre-exposure Prophylaxis (PrEP) Adherence for Sexual and Gender Minority (SGM) Youth Living in the United States. AIDS and Behavior. 29(2). 652–663. 1 indexed citations

Shrivastava, Roopali, Craig Sykes, Amanda P. Schauer, et al.. (2023). Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming Implant. Pharmaceutics. 15(5). 1487–1487.

Cottrell, Mackenzie L., et al.. (2023). AmulticompartmentpopulationPKmodel to predict tenofovir and emtricitabine mucosal tissue concentrations forHIVprevention. CPT Pharmacometrics & Systems Pharmacology. 12(12). 1922–1930. 1 indexed citations

Shrivastava, Roopali, Sarah A. Howard, Mackenzie L. Cottrell, et al.. (2022). Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant Pharmacokinetics. Pharmaceutics. 14(3). 615–615. 8 indexed citations

Zerbato, Jennifer M., Anchalee Avihingsanon, Kasha P. Singh, et al.. (2022). HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. EBioMedicine. 87. 104391–104391. 18 indexed citations

10.

Herrera, Carolina, Mackenzie L. Cottrell, Angela D. M. Kashuba, et al.. (2022). The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans. iScience. 25(6). 104409–104409. 3 indexed citations

11.

Imaz, Arkaitz, Mackenzie L. Cottrell, Jordí Niubó, et al.. (2022). Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide. Clinical Infectious Diseases. 75(11). 2012–2015.

12.

Scorgie, Fiona, Lee Fairlie, Florence Mathebula, et al.. (2022). Acceptability of Implants for HIV Treatment in Young Children: Perspectives of Health Care Providers in Johannesburg, South Africa. AIDS Patient Care and STDs. 36(10). 389–395. 2 indexed citations

13.

Blažková, Jana, Feng Gao, Manukumar Honnayakanahalli Marichannegowda, et al.. (2021). Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy. Nature Medicine. 27(11). 1893–1898. 31 indexed citations

14.

Maturavongsadit, Panita, Roopali Shrivastava, Craig Sykes, et al.. (2021). Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs. International Journal of Pharmaceutics. 605. 120844–120844. 17 indexed citations

15.

Nicol, Melanie R., Mackenzie L. Cottrell, Amanda Corbett, et al.. (2020). Endogenous Hormones and Antiretroviral Exposure in Plasma, Cervicovaginal Fluid, and Upper-Layer Packed Cells of Malawian Women Living with HIV. AIDS Research and Human Retroviruses. 36(8). 641–646. 3 indexed citations

16.

Brocca‐Cofano, Egidio, Cuiling Xu, Katherine S. Wetzel, et al.. (2018). Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques. Journal of Virology. 92(17). 12 indexed citations

17.

Mitchell, John T., Sara LeGrand, Lisa Hightow‐Weidman, et al.. (2018). Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial. JMIR mhealth and uhealth. 6(9). e10456–e10456. 42 indexed citations

18.

Krovi, Sai Archana, Matthew D. Gallovic, Menakshi Bhat, et al.. (2018). Injectable long-acting human immunodeficiency virus antiretroviral prodrugs with improved pharmacokinetic profiles. International Journal of Pharmaceutics. 552(1-2). 371–377. 7 indexed citations

19.

Feder, Alison F., Christopher E. Kline, Patricia Polacino, et al.. (2017). A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host. PLoS Pathogens. 13(5). e1006358–e1006358. 17 indexed citations

20.

Cottrell, Mackenzie L., Kuo H. Yang, Heather M. A. Prince, et al.. (2014). Predicting Effective Truvada ^® PrEP Dosing Strategies With a Novel PK-PD Model Incorporating Tissue Active Metabolites and Endogenous Nucleotides (EN). AIDS Research and Human Retroviruses. 30(S1). A60–A60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact